Human trypsinogens in the pancreas and in cancer

References

• Rinderknecht H, Renner IG, Carmack C. Trypsinogen variants in pancreatic juice of healthy volunteers, chronic alcoholics, and patients with pancreatitis and cancer of the pancreas. Gut 1979;20:886–91.
   PubMed Web of Science ®Google Scholar
• Scheele G, Bartelt D, Bieger W. Characterization of human exocrine pancreatic proteins by two-dimensional isoelectric focusing/sodium dodecyl sulfate gel electrophoresis. Gastroenterology 1981;80:461–73.
   PubMed Web of Science ®Google Scholar
• Huhtala ML, Pesonen K, Kalkkinen N, Stenman UH. Purification and characterization of a tumor-associated trypsin inhibitor from the urine of a patient with ovarian cancer. J Biol Chem 1982;257:13713–6.
   PubMed Web of Science ®Google Scholar
• Koivunen E, Huhtala ML, Stenman UH. Human ovarian tumor-associated trypsin. Its purification and characterization from mucinous cyst fluid and identification as an activator of pro-urokinase. J Biol Chem 1989;264:14095–9.
   PubMed Web of Science ®Google Scholar
• Bohe M, Borgstrom A, Lindstrom C, Ohlsson K. Pancreatic endoproteases and pancreatic secretory trypsin inhibitor immunoreactivity in human Paneth cells. J Clin Pathol 1986;39:786–93.
   PubMed Web of Science ®Google Scholar
• Emi M, Nakamura Y, Ogawa M, Yamamoto T, Nishide T, Mori T, Matsubara K. Cloning, characterization and nucleotide sequences of two cDNAs encoding human pancreatic trypsinogens. Gene 1986;41:305–10.
   PubMed Web of Science ®Google Scholar
• Rowen L, Koop BF, Hood L. The complete 685-kilobase DNA sequence of the human beta T cell receptor locus. Science 1996;272:1755–62.
   PubMed Web of Science ®Google Scholar
• Wiegand U, Corbach S, Minn A, Kang J, Muller-Hill B. Cloning of the cDNA encoding human brain trypsinogen and characterization of its product. Gene 1993;136:167–75.
   PubMed Web of Science ®Google Scholar
• Szmola R, Sahin-Toth M. Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: identity with Rinderknecht’s enzyme Y. Proc Natl Acad Sci USA 2007;104:11227–32.
   PubMed Web of Science ®Google Scholar
• Nguyen TD, Moody MW, Steinhoff M, Okolo C, Koh DS, Bunnett NW. Trypsin activates pancreatic duct epithelial cell ion channels through proteinase-activated receptor-2. J Clin Invest 1999;103:261–9.
   PubMed Web of Science ®Google Scholar
• Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980; 284:67–8.
   PubMed Web of Science ®Google Scholar
• Paju A, Stenman UH. Biochemistry and clinical role of trypsinogens and pancreatic secretory trypsin inhibitor. Crit Rev Clin Lab Sci 2006;43:103–42.
   PubMed Web of Science ®Google Scholar
• Koivunen E, Ristimaki A, Itkonen O, Osman S, Vuento M, Stenman UH. Tumor-associated trypsin participates in cancer cell-mediated degradation of extracellular matrix. Cancer Res 1991;51:2107–12.
   PubMed Web of Science ®Google Scholar
• Stenman M, Ainola M, Valmu L, Bjartell A, Ma G, Stenman UH, Sorsa T, Luukkainen R, Konttinen YT. Trypsin-2 degrades human type II collagen and is expressed and activated in mesenchymally transformed rheumatoid arthritis synovitis tissue. Am J Pathol 2005;167:1119–24.
   PubMed Web of Science ®Google Scholar
• Koivunen E, Itkonen O, Halila H, Stenman UH. Cyst fluid of ovarian cancer patients contains high concentrations of trypsinogen-2. Cancer Res 1990;50:2375–8.
   PubMed Web of Science ®Google Scholar
• Cederqvist K, Haglund C, Heikkila P, Sorsa T, Tervahartiala T, Stenman UH, Andersson S. Pulmonary trypsin-2 in the development of bronchopulmonary dysplasia in preterm infants. Pediatrics 2003;112:570–7.
   PubMed Web of Science ®Google Scholar
• Ghosh D, Porter E, Shen B, Lee SK, Wilk D, Drazba J, Yadav SP, Crabb JW, Ganz T, Bevins CL. Paneth cell trypsin is the processing enzyme for human defensin-5. Nat Immunol 2002;3:583–90.
   PubMed Web of Science ®Google Scholar
• Kazal LA, Spicer DS, Brahinsky RA. Isolation of a crystalline trypsin inhibitor-anticoagulant protein from the pancreas. J Am Chem Soc 1948;70:437–44.
   PubMed Web of Science ®Google Scholar
• Rinderknecht H. Activation of pancreatic zymogens. Normal activation, premature intrapancreatic activation, protective mechanisms against inappropriate activation. Dig Dis Sci 1986;31:314–21.
   PubMed Web of Science ®Google Scholar
• Stenman UH, Huhtala ML, Koistinen R, Seppala M. Immunochemical demonstration of an ovarian cancer- associated urinary peptide. Int J Cancer 1982;30:53–7.
   PubMed Web of Science ®Google Scholar
• Yasuda T, Ogawa M, Murata A, Oka Y, Uda K, Mori T. Response to IL-6 stimulation of human hepatoblastoma cells: production of pancreatic secretory trypsin inhibitor. Biol Chem Hoppe Seyler 1990;371:95–100.
   PubMed Web of Science ®Google Scholar
• Pubols MH, Bartelt DC, Greene LJ. Trypsin inhibitor from human pancreas and pancreatic juice. J Biol Chem 1974;249: 2235–42.
   PubMed Web of Science ®Google Scholar
• Fukayama M, Hayashi Y, Koike M, Ogawa M, Kosaki G. Immunohistochemical localization of pancreatic secretory trypsin inhibitor in fetal and adult pancreatic and extrapancreatic tissues. J Histochem Cytochem 1986;34:227–35.
   PubMed Web of Science ®Google Scholar
• Halila H, Huhtala ML, Schroder T, Kiviluoto T, Stenman UH. Pancreatic secretory trypsin inhibitor-like immunoreactivity in pancreatectomized patients. Clin Chim Acta 1985; 153:209–16.
   PubMed Web of Science ®Google Scholar
• Itkonen O, Koivunen E, Hurme M, Alfthan H, Schroder T, Stenman UH. Time-resolved immunofluorometric assays for trypsinogen-1 and 2 in serum reveal preferential elevation of trypsinogen-2 in pancreatitis. J Lab Clin Med 1990; 115:712–8.
   PubMed Web of Science ®Google Scholar
• Lafont P, Guy-Crotte O, Paulin C, Galvain D, Mertani S, Figarella C, Barbier Y. A specific immunoradiometric assay of cationic trypsin(ogen) that does not recognize trypsin-alpha-1-proteinase inhibitor complex. Clin Chim Acta 1995; 235:197–206.
   PubMed Web of Science ®Google Scholar
• Kukor Z, Toth M, Sahin-Toth M. Human anionic trypsinogen: properties of autocatalytic activation and degradation and implications in pancreatic diseases. Eur J Biochem 2003; 270:2047–58.
   PubMedGoogle Scholar
• Geokas MC, Largman C, Brodrick JW, Johnson JH. Determination of human pancreatic cationic trypsinogen in serum by radioimmunoassay. Am J Physiol 1979;236:E77–83.
   PubMed Web of Science ®Google Scholar
• Florholmen J, Jorde R, Olsen RL, Kolmannskog S, Burhol PG. Radioimmunoassay of cationic trypsin-like immunoreactivity in man. Scand J Gastroenterol 1984;19:613–21.
   PubMed Web of Science ®Google Scholar
• Borgstrom A, Ohlsson K. Radioimmunological determination and characterization of cathodal trypsin-like immunoreactivity in normal human plasma. Scand J Clin Lab Invest 1976;36:809–14.
   PubMed Web of Science ®Google Scholar
• Kimland M, Russick C, Marks WH, Borgstrom A. Immunoreactive anionic and cationic trypsin in human serum. Clin Chim Acta 1989;184:31–46.
   PubMed Web of Science ®Google Scholar
• Largman C, Brodrick JW, Geokas MC, Johnson JH. Demonstration of human pancreatic anionic trypsinogen in normal serum by radioimmunoassay. Biochim Biophys Acta 1978;543:450–4.
   PubMed Web of Science ®Google Scholar
• Petersson U, Appelros S, Borgstrom A. Different patterns in immunoreactive anionic and cationic trypsinogen in urine and serum in human acute pancreatitis. Int J Pancreatol 1999;25:165–70.
   PubMedGoogle Scholar
• Itkonen O, Stenman UH, Osman S, Koivunen E, Halila H, Schroder T. Serum samples from pancreatectomized patients contain trypsinogen immunoreactivity. J Lab Clin Med 1996;128:98–102.
   PubMed Web of Science ®Google Scholar
• Koshikawa N, Hasegawa S, Nagashima Y, Mitsuhashi K, Tsubota Y, Miyata S, Miyagi Y, Yasumitsu H, Miyazaki K. Expression of trypsin by epithelial cells of various tissues, leukocytes, and neurons in human and mouse. Am J Pathol 1998;153:937–44.
   PubMed Web of Science ®Google Scholar
• Kloppel G, Adsay NV, Klimstra DS. Pancreatitis: an introduction to history, etiology and pathogenesis. Semin Diagn Pathol 2004;21:219–20.
   PubMed Web of Science ®Google Scholar
• Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD, Martin SP, Gates LK, Jr, Amann ST, Toskes PP, Liddle R, McGrath K, Uomo G, Post JC, Ehrlich GD. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996;14:141–5.
   PubMed Web of Science ®Google Scholar
• Gaboriaud C, Serre L, Guy-Crotte O, Forest E, Fontecilla-Camps JC. Crystal structure of human trypsin 1: unexpected phosphorylation of Tyr151. J Mol Biol 1996;259:995–1010.
   PubMed Web of Science ®Google Scholar
• Itkonen O, Helin J, Saarinen J, Kalkkinen N, Ivanov KI, Stenman UH, Valmu L. Mass spectrometric detection of tyrosine sulfation in human pancreatic trypsinogens, but not in tumor-associated trypsinogen. FEBS J 2008;275: 289–301.
   PubMed Web of Science ®Google Scholar
• Sahin-Toth M, Kukor Z, Nemoda Z. Human cationic trypsinogen is sulfated on Tyr154. FEBS J 2006;273:5044–50.
   PubMed Web of Science ®Google Scholar
• Szilagyi L, Kenesi E, Katona G, Kaslik G, Juhasz G, Graf L. Comparative in vitro studies on native and recombinant human cationic trypsins. Cathepsin B is a possible pathological activator of trypsinogen in pancreatitis. J Biol Chem 2001;276:24574–80.
   PubMed Web of Science ®Google Scholar
• Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245: 1066–73.
   PubMed Web of Science ®Google Scholar
• Castellani C, Bonizzato A, Mastella G. CFTR mutations and IVS8-5T variant in newborns with hypertrypsinaemia and normal sweat test. J Med Genet 1997;34:297–301.
   PubMed Web of Science ®Google Scholar
• Petersson U, Borgstrom A. Characterization of immunoreactive trypsinogen activation peptide in urine in acute pancreatitis. Jop 2006;7:274–82.
   PubMedGoogle Scholar
• Hedstrom J, Sainio V, Kemppainen E, Haapiainen R, Kivilaakso E, Schroder T, Leinonen J, Stenman UH. Serum complex of trypsin 2 and alpha 1 antitrypsin as diagnostic and prognostic marker of acute pancreatitis: clinical study in consecutive patients.see comment. BMJ 1996;313:333–7.
   PubMed Web of Science ®Google Scholar
• Hedstrom J, Korvuo A, Kenkimaki P, Tikanoja S, Haapiainen R, Kivilaakso E, Stenman UH. Urinary trypsinogen-2 test strip for acute pancreatitis. Lancet 1996;347:729–30.
   PubMed Web of Science ®Google Scholar
• Lieberman JM, Marks WH, Stuart FP, Abecassis MM, Florence LS, Kauffman D. Co-monitoring serum anodal trypsinogen, serum amylase, and serum creatinine accurately differentiates rejection from other causes of allograft dysfunction after simultaneous pancreas-kidney transplantation. Transplant Proc 1997;29:676–7.
   PubMed Web of Science ®Google Scholar
• Durie PR, Forstner GG, Gaskin KJ, Weizman Z, Kopelman HR, Ellis L, Largman C. Elevated serum immunoreactive pancreatic cationic trypsinogen in acute malnutrition: evidence of pancreatic damage. J Pediatr 1985;106:233–8.
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Iku S, Adachi Y, Imsumran A, Taniguchi H, Nosho K, Min Y, Horiuchi S, Yoshida M, Itoh F, Imai K. Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer. J Pathol 2003;199:176–84.
   PubMed Web of Science ®Google Scholar
• Diederichs S, Bulk E, Steffen B, Ji P, Tickenbrock L, Lang K, Zanker KS, Metzger R, Schneider PM, Gerke V, Thomas M, Berdel WE, Serve H, Muller-Tidow C. S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer. Cancer Res 2004;64:5564–9.
   PubMed Web of Science ®Google Scholar
• Lempinen M, Isoniemi H, Makisalo H, Nordin A, Halme L, Arola J, Hockerstedt K, Stenman UH. Enhanced detection of cholangiocarcinoma with serum trypsinogen-2 in patients with severe bile duct strictures. J Hepatol 2007; 47:677–83.
   PubMed Web of Science ®Google Scholar